These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2203523)

  • 21. Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation.
    Krishnamurthy S; Huang Z; Samal SK
    Virology; 2000 Dec; 278(1):168-82. PubMed ID: 11112492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus.
    Vigil A; Park MS; Martinez O; Chua MA; Xiao S; Cros JF; Martínez-Sobrido L; Woo SL; García-Sastre A
    Cancer Res; 2007 Sep; 67(17):8285-92. PubMed ID: 17804743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two avirulent, lentogenic strains of Newcastle disease virus are cytotoxic for some human pancreatic tumor lines in vitro.
    Walter RJ; Attar BM; Rafiq A; Delimata M; Tejaswi S
    JOP; 2012 Sep; 13(5):502-13. PubMed ID: 22964957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
    Vähä-Koskela MJ; Kallio JP; Jansson LC; Heikkilä JE; Zakhartchenko VA; Kallajoki MA; Kähäri VM; Hinkkanen AE
    Cancer Res; 2006 Jul; 66(14):7185-94. PubMed ID: 16849565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of metastatic variants from heterogeneous tumor cell lines using the chicken chorioallantoic membrane and nude mouse.
    Dexter DL; Lee ES; DeFusco DJ; Libbey NP; Spremulli EN; Calabresi P
    Cancer Res; 1983 Apr; 43(4):1733-40. PubMed ID: 6831418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of field isolates of Newcastle disease virus using antipeptide antibodies.
    Hodder AN; Liu ZY; Selleck PW; Corino GL; Shiell BJ; Grix DC; Morrow CJ; Gorman JJ
    Avian Dis; 1994; 38(1):103-18. PubMed ID: 8002877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of a velogenic Newcastle disease virus from cDNA and expression of the green fluorescent protein.
    Liu YL; Hu SL; Zhang YM; Sun SJ; Romer-Oberdorfer A; Veits J; Wu YT; Wan HQ; Liu XF
    Arch Virol; 2007; 152(7):1241-9. PubMed ID: 17393069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virus isolation from tracheal explant cultures and oropharyngeal swabs in attempts to detect persistent Newcastle disease virus infections in chickens.
    King DJ
    Avian Dis; 1985; 29(2):297-311. PubMed ID: 4026728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA amplification and tumorigenicity of the human melanoma cell line MeWo.
    Shtromas I; White BN; Holden JJ; Reimer DL; Roder JC
    Cancer Res; 1985 Feb; 45(2):642-7. PubMed ID: 3967240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytopathic effect of lentogenic strains of Newcastle disease virus in cultured chicken muscle cells.
    Palmieri S; Bennett JD
    Avian Dis; 1990; 34(3):729-35. PubMed ID: 2146945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.
    Koks CA; Garg AD; Ehrhardt M; Riva M; Vandenberk L; Boon L; De Vleeschouwer S; Agostinis P; Graf N; Van Gool SW
    Int J Cancer; 2015 Mar; 136(5):E313-25. PubMed ID: 25208916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engagement of new castle disease virus (NDV) matrix (M) protein with charged multivesicular body protein (CHMP) 4 facilitates viral replication.
    Li X; Li X; Cao H; Wang Y; Zheng SJ
    Virus Res; 2013 Jan; 171(1):80-8. PubMed ID: 23142758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo.
    Alabsi AM; Ali R; Ideris A; Omar AR; Bejo MH; Yusoff K; Ali AM
    Leuk Res; 2012 May; 36(5):634-45. PubMed ID: 22133641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Roles of Newcastle disease virus in human acute monocytic leukemia in vitro and in vivo].
    Wang YJ; Song C; Li XH; Zhang JB
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Feb; 13(2):149-52. PubMed ID: 21342628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Introduction of adhesive and costimulatory immune functions into tumor cells by infection with Newcastle Disease Virus.
    Haas C; Ertel C; Gerhards R; Schirrmacher V
    Int J Oncol; 1998 Dec; 13(6):1105-15. PubMed ID: 9824618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: effects on pathogenicity.
    Garten W; Berk W; Nagai Y; Rott R; Klenk HD
    J Gen Virol; 1980 Sep; 50(1):135-47. PubMed ID: 7441209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newcastle disease virus Malaysian strain AF2240 induces apoptosis in MCF-7 human breast carcinoma cells at an early stage of the virus life cycle.
    Ghrici M; El Zowalaty M; Omar AR; Ideris A
    Int J Mol Med; 2013 Mar; 31(3):525-32. PubMed ID: 23337979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of a novel mutant mouse cell line resistant to Newcastle disease virus: constitutive interferon production and enhanced interferon sensitivity.
    Aoki K; Oh-hira M; Hoshino M; Kawakita M
    Arch Virol; 1994; 139(3-4):337-50. PubMed ID: 7832640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newcastle disease virus selectively kills human tumor cells.
    Reichard KW; Lorence RM; Cascino CJ; Peeples ME; Walter RJ; Fernando MB; Reyes HM; Greager JA
    J Surg Res; 1992 May; 52(5):448-53. PubMed ID: 1619912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The spread of a pathogenic and an apathogenic strain of Newcastle disease virus in the chick embryo as depending on the protease sensitivity of the virus glycoproteins.
    Nagai Y; Shimokata K; Yoshida T; Hamaguchi M; Iinuma M; Maeno K; Matsumoto T; Klenk HD; Rott R
    J Gen Virol; 1979 Nov; 45(2):263-72. PubMed ID: 396357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.